340B Drug Pricing Program Contributes to Rising Healthcare Costs and Is Ripe for Reform
The U.S. House Energy & Commerce Committee's Health Subcommittee today will host the third hearing in its health care affordability series, specifically examining the role providers and hospitals play in shaping the cost of care for Americans.
While the hearing will likely examine numerous issues, there is none more ripe for reform than the flawed 340B drug pricing program.
Originally enacted to help eligible safety-net providers buy medicines at steep discounts and pass the savings on to lower-income and vulnerable patients, the program has ballooned as a revenue stream for many participating hospitals and contract pharmacy chains.
As the size and complexity of the 340B program has expanded, participating hospitals and contract pharmacies have instead used the program to increase…[more]
By Victor Davis Hanson
Thursday, September 02 2021
It is the beginning of a never-ending bad dream. Joe Biden and the Pentagon have managed to birth a new terrorist haven, destroy much of U.S. strategic deterrence, and alienate our allies and much of the country.
In the hours after the horrific deaths of 13 service members, we have been reassured by our military that our partnership with the Taliban to provide security for our flights was wise. We were told that the terrorist victors share similar goals to ours in a hasty American retreat from Kabul. We were reminded that Afghan refugees (unlike U.S. soldiers) will not be forced to be vaccinated…
